Testing effectiveness (Phase 2)Study completedNCT00814255What this trial is testingNovel Therapies for Resistant FSGS (FONTII): Phase II Clinical TrialWho this might be right forFocal Segmental Glomerulosclerosis NYU Langone Health 32